Better Therapeutics Valuation

Based on Macroaxis valuation methodology, the firm cannot be evaluated at this time. Better Therapeutics prevailing Real Value cannot be determined due to lack of data. The current price of Better Therapeutics is $0.0. Our model approximates the value of Better Therapeutics from analyzing the firm fundamentals such as Shares Owned By Insiders of 53.41 %, return on equity of -10.22, and Current Valuation of 8.83 M as well as examining its technical indicators and probability of bankruptcy. . In general, most investors favor acquiring undervalued instruments and dropping overvalued instruments since, at some point, asset prices and their ongoing real values will blend.

Better Therapeutics Total Value Analysis

Better Therapeutics is currently anticipated to have valuation of 8.83 M with market capitalization of 1.12 M, debt of 14.88 M, and cash on hands of 29.68 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Better Therapeutics fundamentals before making equity appraisal based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
8.83 M
1.12 M
14.88 M
29.68 M

Better Therapeutics Asset Utilization

One of the ways to look at asset utilization of Better is to check how much profit was generated for every dollar of assets it reports. Better Therapeutics shows a negative utilization of assets of -0.95 percent, losing $0.009505 for each dollar of assets held by the firm. Inadequate asset utilization signifies that the company is being less effective with each dollar of assets it shows. Put another way, asset utilization of Better Therapeutics shows how discouraging it operates for each dollar spent on its assets.

Better Therapeutics Ownership Allocation

Better Therapeutics holds a total of 54.52 Million outstanding shares. Better Therapeutics retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.

Better Therapeutics Profitability Analysis

Net Loss for the year was (31.57 M) with loss before overhead, payroll, taxes, and interest of (674 K).

Better Therapeutics Growth Indicators

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
Common Stock Shares Outstanding23.6 M
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in estimate.
You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.

Other Consideration for investing in Better OTC Stock

If you are still planning to invest in Better Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Better Therapeutics' history and understand the potential risks before investing.
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets